Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma

Authors: Stefan K. Barta, Jasmine Zain, Alexander W. Macfarlane, Sonali M. Smith, Jia Ruan, Henry C. Fung, Carlyn Tan, Yibin Yang, R. Katherine Alpaugh, Essel Dulaimi, Eric A. Ross, Kerry S. Campbell, Nadia Khan, Rawat Siddharta, Nathan Fowler, Richard I. Fisher, Yasuhiro Oki - Clinical Lymphoma Myeloma & Leukemia 2019 cited by 117